Infosys | INFO

Stock Price
1,875.45
Daily Change
10.00 0.54%
Monthly
-1.76%
Yearly
12.36%
Q1 Forecast
1,848.76



Peers Price Chg Day Year Date
Ambuja Cements 552.05 4.30 0.79% -1.45% Jan/24
Asian Paints 2,262.40 -13.95 -0.61% -23.29% Jan/24
Cognizant Technology Solutions 80.05 0.44 0.55% 2.23% Jan/24
HCL Tech 1,792.85 -14.15 -0.78% 15.65% Jan/24
Infosys 1,875.45 10.00 0.54% 12.36% Jan/24
Tata Consultancy 4,152.35 6.90 0.17% 8.98% Jan/24
Tata Motors 734.10 -18.40 -2.45% -9.58% Jan/24
Wipro 320.10 2.40 0.76% 36.21% Jan/24

Indexes Price Day Year Date
SENSEX 76190 -329.92 -0.43% 7.76% Jan/24
NIFTY 50 23092 -113.15 -0.49% 8.15% Jan/24

Infosys traded at 1,875.45 this Friday January 24th, increasing 10.00 or 0.54 percent since the previous trading session. Looking back, over the last four weeks, Infosys gained 1.76 percent. Over the last 12 months, its price rose by 12.36 percent. Looking ahead, we forecast Infosys to be priced at 1,848.76 by the end of this quarter and at 1,801.47 in one year, according to Trading Economics global macro models projections and analysts expectations.

Infosys Limited is engaged in consulting, technology, outsourcing and next-generation services. The Company, along with its subsidiaries, provides business information technology services comprising application development and maintenance, independent validation, infrastructure management, engineering services comprising product engineering and life cycle solutions and business process management; consulting and systems integration services comprising consulting, enterprise solutions, systems integration and advanced technologies; products, business platforms and solutions to accelerate intellectual property-led innovation, including Finacle, its banking solution, and offerings in the areas of Analytics, Cloud and Digital Transformation. Its segments are Financial Services and Insurance (FSI), Manufacturing and Hi-tech (MFG & Hi-TECH), Energy & utilities, Communication and Services (ECS), Retail, Consumer packaged goods and Logistics (RCL), and Life Sciences and Healthcare (LSH).